Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cure Parkinson's Trust names chair

This article was originally published in Scrip

Executive Summary

The Cure Parkinson's Trust, a charity which aims to fund and facilitate work towards a cure for Parkinson's disease, has appointed Ken Mulvany as chair. Prior to joining the charity Mr Mulvany served as chief executive officer of UK-based biotech company Proximagen, which was acquired by Upsher-Smith laboratories in 2012. Sir Richard Nichols, former Lord Mayor of London and co-founder of the charity, has stepped down after eight years as chair. Initiatives orchestrated by CPT are: Linked Clinical Trials initiative, Sense-Park initiative and Parkinson's Movement.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts